May 19, 2026 a 08:38 pm

SYK: Analysts Ratings - Stryker Corporation

Historical Stock Grades

The latest analyst ratings for Stryker Corporation reveal a strong confidence in the stock, with no "Sell" or "Strong Sell" grades provided as of May 2026. A full summary is showcased below with visual indicators of the ratings' distribution:

Rating	Count	Score
Strong Buy	8
Buy	14
Hold	7
Sell	0
Strong Sell	0

Sentiment Development

• The number of "Strong Buy" ratings has remained relatively stable, indicating continuing strong confidence from analysts.
• "Buy" ratings have experienced slight fluctuations, demonstrating some adjustments in short-term sentiment.
• "Hold" ratings saw a minor increase in the earlier months but have slightly decreased back to 7, suggesting some caution being applied by analysts.
• A consistent absence of "Sell" and "Strong Sell" ratings reflects the stock's strong standing in the current market climate.

Percentage Trends

• A decline in "Strong Buy" ratings was noted earlier, but stability has resumed in recent months.
• There has been a slight increase in the "Hold" category over time, showcasing a cautious stance from some analysts
• The "Buy" ratings consistently represent the largest category, with an approximate 50% share of total ratings.
• Overall stability in ratings distribution indicates a positive sentiment maintained over the past year.

Latest Analyst Recommendations

Date	New Recommendation	Last Recommendation	Publisher
2026-05-04	Overweight	Overweight	Barclays
2026-05-04	Hold	Hold	Truist Securities
2026-05-01	Overweight	Overweight	JP Morgan
2026-05-01	Buy	Buy	BTIG
2026-05-01	Buy	Buy	Canaccord Genuity

Analyst Recommendations with Change of Opinion

Analysts have adjusted their ratings notably, in a positive direction over the past years:

Date	New Recommendation	Last Recommendation	Publisher
2025-12-19	Market Outperform	Market Perform	Citizens
2024-12-02	Overweight	Equal Weight	Morgan Stanley
2024-05-22	Buy	Hold	Needham
2024-01-31	Buy	Hold	Canaccord Genuity
2023-09-05	Buy	Neutral	B of A Securities

Interpretation

The analyst ratings for Stryker Corporation suggest an optimistic market sentiment, with prevalent "Buy" and "Strong Buy" recommendations indicating strong confidence in the company's strategic direction and financial health. Notably, the persistently low "Sell" ratings point toward a stable outlook. Analysts' changes in opinion, predominantly in positive directions, underscore robust performance expectations. However, increased "Hold" ratings signify cautious watchfulness, likely due to broader market uncertainties. Overall, analyst confidence in Stryker's market position remains solid.

Conclusion

Stryker Corporation demonstrates a resilient position in the medical technology sector, backed by strong and stable analyst recommendations. The shift in ratings towards more conservative "Hold" positions highlights market caution, yet the consistent "Buy" ratings affirm Stryker's ongoing strength. Potential risks include market volatilities affecting sentiment. However, Stryker's broad international presence and diverse product portfolio present solid growth opportunities. Analysts generally maintain a positive stance, reflecting a belief in the firm’s capability to navigate industry challenges.